IL183581A - Use of viscosity supplements to treat osteoarthritis - Google Patents

Use of viscosity supplements to treat osteoarthritis

Info

Publication number
IL183581A
IL183581A IL183581A IL18358107A IL183581A IL 183581 A IL183581 A IL 183581A IL 183581 A IL183581 A IL 183581A IL 18358107 A IL18358107 A IL 18358107A IL 183581 A IL183581 A IL 183581A
Authority
IL
Israel
Prior art keywords
viscosupplementation
compositions
treating osteoarthritis
osteoarthritis
treating
Prior art date
Application number
IL183581A
Other languages
English (en)
Hebrew (he)
Other versions
IL183581A0 (en
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36633154&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL183581(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of IL183581A0 publication Critical patent/IL183581A0/en
Publication of IL183581A publication Critical patent/IL183581A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
IL183581A 2004-12-30 2007-05-31 Use of viscosity supplements to treat osteoarthritis IL183581A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64074904P 2004-12-30 2004-12-30
PCT/US2005/046409 WO2006073835A2 (en) 2004-12-30 2005-12-20 Regiments for intra-articular viscosupplementation

Publications (2)

Publication Number Publication Date
IL183581A0 IL183581A0 (en) 2007-10-31
IL183581A true IL183581A (en) 2016-10-31

Family

ID=36633154

Family Applications (1)

Application Number Title Priority Date Filing Date
IL183581A IL183581A (en) 2004-12-30 2007-05-31 Use of viscosity supplements to treat osteoarthritis

Country Status (16)

Country Link
US (4) US7931030B2 (cg-RX-API-DMAC7.html)
EP (5) EP2664336A3 (cg-RX-API-DMAC7.html)
JP (4) JP5725594B2 (cg-RX-API-DMAC7.html)
KR (3) KR20140041926A (cg-RX-API-DMAC7.html)
CN (4) CN101094680A (cg-RX-API-DMAC7.html)
AU (1) AU2005323095B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0518542A2 (cg-RX-API-DMAC7.html)
CA (2) CA2744999A1 (cg-RX-API-DMAC7.html)
DK (2) DK1835923T3 (cg-RX-API-DMAC7.html)
ES (2) ES2537751T3 (cg-RX-API-DMAC7.html)
HU (1) HUE025255T2 (cg-RX-API-DMAC7.html)
IL (1) IL183581A (cg-RX-API-DMAC7.html)
PL (2) PL1835923T3 (cg-RX-API-DMAC7.html)
PT (2) PT1835923E (cg-RX-API-DMAC7.html)
SI (2) SI1835923T1 (cg-RX-API-DMAC7.html)
WO (1) WO2006073835A2 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2891651B2 (ja) 1995-07-03 1999-05-17 三菱重工業株式会社 Ｃ型コイル
US20040081704A1 (en) 1998-02-13 2004-04-29 Centerpulse Biologics Inc. Implantable putty material
US20020114795A1 (en) 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
CN101094680A (zh) * 2004-12-30 2007-12-26 建新公司 用于关节内粘弹性补充的方案
CA2633978A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
CA2633957A1 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
EP1968498A2 (en) * 2005-12-14 2008-09-17 Anika Therapeutics Inc. Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
CN101573123B (zh) 2006-12-06 2013-06-05 生化学工业株式会社 治疗关节炎病症的长效药剂
US7718616B2 (en) 2006-12-21 2010-05-18 Zimmer Orthobiologics, Inc. Bone growth particles and osteoinductive composition thereof
JP5722217B2 (ja) 2008-09-02 2015-05-20 アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎ Ｈｏｌｄｉｎｇｓ Ｆｒａｎｃｅ Ｓ．Ａ．Ｓ． ヒアルロン酸および／またはその誘導体の糸、その作製方法、ならびにその使用
EP2451381B1 (en) * 2009-07-10 2016-04-06 Kirk Promotion LTD. Implantable medical device for lubrication of a synovial joint
JO3008B1 (ar) 2009-08-13 2016-09-05 Seikagaku Kogyo Co Ltd تركيب صيدلي لتخفيف الألم
CA2809228C (en) 2010-08-23 2018-01-23 Denki Kagaku Kogyo Kabushiki Kaisha Crosslinked hyaluronic acid composition and self-crosslinking hyaluronic acid particles
JP2013542837A (ja) 2010-11-15 2013-11-28 ジンマー オーソバイオロジクス，インコーポレイティド 骨空隙充填剤
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
PT3019177T (pt) * 2013-07-10 2020-12-30 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
KR101582380B1 (ko) * 2013-09-11 2016-01-05 주식회사 제네웰 손상 조직에 대한 세포 전달 및 조직 재생용 생체재료와 제조방법
WO2015142781A1 (en) * 2014-03-21 2015-09-24 Rmg, Inc. Mobile based exercise and rehabilitation
GB201408752D0 (en) * 2014-05-16 2014-07-02 Stemmatters Biotecnologia E Medicina Regenerativa Sa Arthritis treatment
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints
US10004824B2 (en) 2015-05-11 2018-06-26 Laboratoires Vivacy Compositions comprising at least one polyol and at least one anesthetic
WO2016034745A2 (en) * 2015-09-22 2016-03-10 Cylenchar Limited A method for concentrating and/or entrapping radioisotopes from an aqueous solution
ES2871199T3 (es) 2015-09-24 2021-10-28 Matrix Biology Inst Composiciones de hialuronano de alta elasticidad y métodos de uso de las mismas
KR20170090965A (ko) * 2016-01-29 2017-08-08 한미약품 주식회사 복합 히알루론산 가교물 및 그 제조방법
JP2021520484A (ja) * 2018-04-03 2021-08-19 サノフイＳａｎｏｆｉ ラテラルフロー免疫アッセイストリップ装置
WO2022051060A1 (en) * 2020-09-01 2022-03-10 Orthogenrx, Inc. Crosslinking of non-animal-derived hyaluronic acid with divinyl sulfone
WO2025068242A1 (en) * 2023-09-25 2025-04-03 Hyamedix Dexamethasone delivery system

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4636524A (en) * 1984-12-06 1987-01-13 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US5128326A (en) * 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US5099013A (en) 1985-03-12 1992-03-24 Biomatrix, Inc, Hylan preparation and method of recovery thereof from animal tissues
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US4803075A (en) * 1986-06-25 1989-02-07 Collagen Corporation Injectable implant composition having improved intrudability
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
US5143724A (en) 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5246698A (en) 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2061566C (en) * 1992-02-20 2002-07-09 Rudolf E. Falk Treatment of disease employing hyaluronic acid and nsaids
US5219360A (en) * 1991-05-10 1993-06-15 Fortis Research Corporation Mammary prosthesis fill and method of making same
US5143351A (en) * 1991-08-29 1992-09-01 Pierce Daniel H Self-locking valve spring retainer
US5690961A (en) * 1994-12-22 1997-11-25 Hercules Incorporated Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5612321A (en) * 1995-06-22 1997-03-18 Hercules Incorporated Antioxidant grafted polysaccharides
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
CN1098863C (zh) * 1995-11-15 2003-01-15 生化学株式会社 光固化交联透明质酸凝胶、其制备方法和生物医学材料
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
CA2539273C (en) * 1996-02-09 2014-02-04 Amgen Inc. A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof
JP3521378B2 (ja) * 1996-08-13 2004-04-19 コニカミノルタホールディングス株式会社 両面複写装置
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
ES2217496T3 (es) * 1998-02-27 2004-11-01 Stichting Hippomedics Proceso para producir acido hialuronico reticulado.
US6630457B1 (en) * 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
JP4551563B2 (ja) 1998-11-10 2010-09-29 電気化学工業株式会社 ヒアルロン酸ゲルの製造方法及び医用材料
US6677321B1 (en) * 1999-12-09 2004-01-13 Bruce Levin Methods and compositions for treatment of inflammatory disease
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
US6800298B1 (en) * 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
US6527760B1 (en) * 2000-09-25 2003-03-04 Vijay B. Vad Out-patient joint lavage kit and protocol
DE60117502T2 (de) * 2000-12-19 2006-08-24 Seikagaku Corp. Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material
US7119062B1 (en) * 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
US20030008817A1 (en) * 2001-07-03 2003-01-09 Tom Sander Cross-link reversing agent
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
BR0308118A (pt) * 2002-03-01 2005-01-11 Warner Lambert Co Método para o tratamento de osteoartrite
US20030232784A1 (en) * 2002-06-14 2003-12-18 Benedict James J. Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
JP4383035B2 (ja) * 2002-10-29 2009-12-16 電気化学工業株式会社 ヒアルロン酸ゲル及びその製造方法
EP2163643B1 (en) * 2003-03-05 2015-01-21 Halozyme, Inc. Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
JP2007507431A (ja) * 2003-10-09 2007-03-29 ロバート・ジョン・ペトレラ ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法
US8524213B2 (en) * 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
US20050142152A1 (en) * 2003-12-30 2005-06-30 Leshchiner Adelya K. Polymeric materials, their preparation and use
WO2006012492A2 (en) * 2004-07-23 2006-02-02 Mucosal Therapeutics Llc Compositions and methods for viscosupplementation
WO2006020994A2 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors
CN101094680A (zh) 2004-12-30 2007-12-26 建新公司 用于关节内粘弹性补充的方案
CA2633957A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

Also Published As

Publication number Publication date
ES2537751T3 (es) 2015-06-11
EP2289523A3 (en) 2011-09-28
CN103860582A (zh) 2014-06-18
JP2015007077A (ja) 2015-01-15
US20060148755A1 (en) 2006-07-06
HUE025255T2 (en) 2016-03-29
PL2664334T3 (pl) 2015-08-31
JP2013035860A (ja) 2013-02-21
CA2744999A1 (en) 2006-07-13
JP6139716B2 (ja) 2017-05-31
US20110183936A1 (en) 2011-07-28
EP1835923B1 (en) 2013-10-09
US20120258931A1 (en) 2012-10-11
CN104689460A (zh) 2015-06-10
PT2664334E (pt) 2015-04-23
AU2005323095B2 (en) 2011-12-15
CA2590159C (en) 2011-07-12
CA2590159A1 (en) 2006-07-13
SI2664334T1 (sl) 2015-06-30
EP2664334A1 (en) 2013-11-20
WO2006073835A2 (en) 2006-07-13
EP1835923A2 (en) 2007-09-26
EP2664336A3 (en) 2015-12-16
KR20140041926A (ko) 2014-04-04
KR101808800B1 (ko) 2018-01-18
EP2664335A2 (en) 2013-11-20
JP2008526747A (ja) 2008-07-24
EP2664335A3 (en) 2015-12-16
BRPI0518542A2 (pt) 2008-11-25
KR20070104579A (ko) 2007-10-26
AU2005323095A1 (en) 2006-07-13
CN104689460B (zh) 2018-03-13
PT1835923E (pt) 2013-11-04
PL1835923T3 (pl) 2014-03-31
SI1835923T1 (sl) 2014-01-31
CN101094680A (zh) 2007-12-26
JP2016128469A (ja) 2016-07-14
WO2006073835A3 (en) 2006-10-05
CN102416020A (zh) 2012-04-18
US20130197444A1 (en) 2013-08-01
EP2289523A2 (en) 2011-03-02
ES2436179T3 (es) 2013-12-27
KR20150052326A (ko) 2015-05-13
DK1835923T3 (da) 2013-10-21
DK2664334T3 (en) 2015-03-23
EP2664334B1 (en) 2015-03-04
US7931030B2 (en) 2011-04-26
EP2664336A2 (en) 2013-11-20
JP5725594B2 (ja) 2015-05-27
IL183581A0 (en) 2007-10-31

Similar Documents

Publication Publication Date Title
IL183581A (en) Use of viscosity supplements to treat osteoarthritis
IL186963A0 (en) Methods and compositions for treating pain
IL227988A0 (en) Use of calcitonin in osteoarthritis
GB2423928B (en) Methods and compositions for treating pain
IL195731A0 (en) Pyrimidine derivatives useful in the treatment of cancer
SI1791791T1 (sl) Postopki in sestavki za obdelavo vode
IL191057A0 (en) Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
EP1973526A4 (en) NEW HAIR TREATMENT COMPOSITIONS
ZA200803524B (en) Hair treatment compositions
IL190520A0 (en) Compositions and methods for treatment of autoimmune
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
EP2049151A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP1959931A4 (en) COMPOSITIONS AND METHODS FOR THE DERMAL TREATMENT OF PAIN
PL1863899T3 (pl) Kompozycje do leczenia skóry
ZA200803523B (en) Hair treatment compositions
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
EP1718280A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
IL187405A0 (en) Methods and compositions for the treatment of pain
IL187531A0 (en) Method and composition for treating osteoarthritis
EP2086560A4 (en) METHODS OF TREATING EPIPHORA
EP1855662A4 (en) METHODS AND COMPOSITIONS FOR TREATING CANCER
EP2124968A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCLE ATROPHY
GB0619816D0 (en) Novel interferon-alpha constructs for use in the treatment of cancer
GB0504657D0 (en) Compositions and methods of treatment

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed